Genetic insights of blood lipid metabolites on polycystic ovary syndrome risk: a bidirectional two-sample Mendelian randomization study

被引:2
作者
Wang, Xinzhe [1 ]
Han, Huawei [2 ]
Shi, Xiuwen [1 ]
Nie, Xiaping [1 ]
Zhu, Rui [1 ]
Jin, Jing [1 ]
Zhou, Huifang [1 ]
机构
[1] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Gynecol, Nanjing, Peoples R China
[2] Nanjing Univ Chinese Med, Affiliated Hosp 2, Dept Orthoped, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
Mendelian randomization; lipid metabolites; polycystic ovarian syndrome; genetics; meta-analysis; metabolic pathway analysis; GAMMA-LINOLENIC ACID; GUT MICROBIOTA; METABOLOMICS; MATURATION; MORTALITY; PROFILES; PATHWAYS; WOMEN; BIAS;
D O I
10.3389/fendo.2024.1391826
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Pathologically, metabolic disorder plays a crucial role in polycystic ovarian syndrome (PCOS). However, there is no conclusive evidence lipid metabolite levels to PCOS risk.Methods In this study, genome-wide association study (GWAS) genetic data for 122 lipid metabolites were used to assign instrumental variables (IVs). PCOS GWAS were derived from a large-scale meta-analysis of 10,074 PCOS cases and 103,164 controls. An inverse variance weighted (IVW) analysis was the primary methodology used for Mendelian randomization (MR). For sensitivity analyses, Cochran Q test, MR-Egger intercept, MR-PRESSO, leave-one-out analysis,and Steiger test were performed. Furthermore, we conducted replication analysis, meta-analysis, and metabolic pathway analysis. Lastly, reverse MR analysis was used to determine whether the onset of PCOS affected lipid metabolites.Results This study detected the blood lipid metabolites and potential metabolic pathways that have a genetic association with PCOS onset. After IVW, sensitivity analyses, replication and meta-analysis, two pathogenic lipid metabolites of PCOS were finally identified: Hexadecanedioate (OR=1.85,95%CI=1.27-2.70, P=0.001) and Dihomo-linolenate (OR=2.45,95%CI=1.30-4.59, P=0.005). Besides, It was found that PCOS may be mediated by unsaturated fatty acid biosynthesis and primary bile acid biosynthesis metabolic pathways. Reverse MR analysis showed the causal association between PCOS and 2-tetradecenoyl carnitine at the genetic level (OR=1.025, 95% CI=1.003-1.048, P=0.026).Conclusion Genetic evidence suggests a causal relationship between hexadecanedioate and dihomo-linolenate and the risk of PCOS. These compounds could potentially serve as metabolic biomarkers for screening PCOS and selecting drug targets. The identification of these metabolic pathways is valuable in guiding the exploration of the pathological mechanisms of PCOS, although further studies are necessary for confirmation.
引用
收藏
页数:10
相关论文
共 49 条
[1]   Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences [J].
Anagnostis, Panagiotis ;
Tarlatzis, Basil C. ;
Kauffman, Robert P. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 86 :33-43
[2]   Metabolomic profiles associated with all-cause mortality in the Women's Health Initiative [J].
Balasubramanian, Raji ;
Paynter, Nina P. ;
Giulianini, Franco ;
Manson, JoAnn E. ;
Zhao, Yibai ;
Chen, Jiu-Chiuan ;
Vitolins, Mara Z. ;
Albert, Christine A. ;
Clish, Clary ;
Rexrode, Kathryn M. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2020, 49 (01) :289-300
[3]   Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator [J].
Bowden, Jack ;
Smith, George Davey ;
Haycock, Philip C. ;
Burgess, Stephen .
GENETIC EPIDEMIOLOGY, 2016, 40 (04) :304-314
[4]   Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression [J].
Bowden, Jack ;
Smith, George Davey ;
Burgess, Stephen .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (02) :512-525
[5]   The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis [J].
Bozdag, Gurkan ;
Mumusoglu, Sezcan ;
Zengin, Dila ;
Karabulut, Erdem ;
Yildiz, Bulent Okan .
HUMAN REPRODUCTION, 2016, 31 (12) :2841-2855
[6]  
Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x
[7]   Bias due to participant overlap in two-sample Mendelian randomization [J].
Burgess, Stephen ;
Davies, Neil M. ;
Thompson, Simon G. .
GENETIC EPIDEMIOLOGY, 2016, 40 (07) :597-608
[8]   Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique [J].
Buszewska-Forajta, Magdalena ;
Rachon, Dominik ;
Stefaniak, Anna ;
Wawrzyniak, Renata ;
Konieczna, Aleksandra ;
Kowalewska, Agnieszka ;
Markuszewski, Michal Jan .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 186 :176-184
[9]   The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study [J].
Chen, Hanxiao ;
Zhang, Yaoyao ;
Li, Shangwei ;
Tao, Yuanzhi ;
Gao, Rui ;
Xu, Wenming ;
Yang, Yihong ;
Cheng, Kemin ;
Wang, Yan ;
Qin, Lang .
FRONTIERS IN ENDOCRINOLOGY, 2021, 12
[10]   Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms [J].
Chiang, JYL .
JOURNAL OF HEPATOLOGY, 2004, 40 (03) :539-551